Cardiotoxicity screening with simultaneous optogenetic pacing, voltage imaging and calcium imaging
- PMID: 27184445
- DOI: 10.1016/j.vascn.2016.05.003
Cardiotoxicity screening with simultaneous optogenetic pacing, voltage imaging and calcium imaging
Abstract
Introduction: The Comprehensive in vitro Proarrhythmia Assay (CiPA) initiative seeks an in vitro test to accurately predict clinical Torsades de Pointes (TdP). We developed a cardiotoxicity assay incorporating simultaneous measurement of the action potential (AP) waveform and Ca(2+) transient (CT) in human iPSC-derived cardiomyocytes (CMs). Concurrent optogenetic pacing provided a well-controlled electrophysiological background.
Methods: We used the Optopatch platform for all-optical electrophysiology (Hochbaum et al., 2014). In a monolayer culture, a subset of cells expressed a genetically encoded, calcium and voltage reporter, CaViar (Hou, Kralj, Douglass, Engert, & Cohen, 2014), while others expressed a channelrhodopsin variant, CheRiff. Optical pacing of CheRiff-expressing cells synchronized the syncytium. We screened 12 compounds (11 acute, 1 chronic) to identify electrophysiological (AP rise time, AP50, AP90, beat rate) and CT effects in spontaneously beating and paced cultures (1Hz, 2Hz).
Results: CaViar reported spontaneous and paced APs and CTs with high signal-to-noise ratio and low phototoxicity. Quinidine, flecainide, E-4031, digoxin and cisapride prolonged APs, while verapamil and nifedipine shortened APs. Early after depolarizations (EADs) were elicited by quinidine, flecainide and cisapride. All but four compounds (amiodarone, chromanol, nifedipine, verapamil) prolonged AP rise time. Nifedipine and verapamil decreased CT amplitude, while digoxin increased CT amplitude. Pentamidine prolonged APs after chronic exposure.
Discussion: The Optopatch platform provides a robust assay to measure APs and CTs in hiPSC-CMs. This addresses the CiPA mandate and will facilitate comparisons of cell-based assays to human clinical data.
Keywords: Cardiomyocytes; Cardiotoxicity; Channelrhodopsin; Comprehensive in vitro Proarrhythmia Assay; Human induced pluripotent stem cells; Methods; Optogenetics; Pacing; Torsades de Pointes; Voltage indicator.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Effects of Electrical Stimulation on hiPSC-CM Responses to Classic Ion Channel Blockers.Toxicol Sci. 2020 Apr 1;174(2):254-265. doi: 10.1093/toxsci/kfaa010. Toxicol Sci. 2020. PMID: 32040191
-
Multi-parametric assessment of cardiomyocyte excitation-contraction coupling using impedance and field potential recording: A tool for cardiac safety assessment.J Pharmacol Toxicol Methods. 2016 Sep-Oct;81:201-16. doi: 10.1016/j.vascn.2016.06.004. Epub 2016 Jun 7. J Pharmacol Toxicol Methods. 2016. PMID: 27282640
-
Assessment of Proarrhythmic Potential of Drugs in Optogenetically Paced Induced Pluripotent Stem Cell-Derived Cardiomyocytes.Toxicol Sci. 2019 Jul 1;170(1):167-179. doi: 10.1093/toxsci/kfz076. Toxicol Sci. 2019. PMID: 30912807
-
Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity.J Appl Toxicol. 2018 Sep;38(9):1166-1176. doi: 10.1002/jat.3611. Epub 2018 Feb 27. J Appl Toxicol. 2018. PMID: 29484688 Review.
-
Cardiotoxicity Assessment of Drugs Using Human iPS Cell-Derived Cardiomyocytes: Toward Proarrhythmic Risk and Cardio-Oncology.Curr Pharm Biotechnol. 2020;21(9):765-772. doi: 10.2174/1389201020666190628143345. Curr Pharm Biotechnol. 2020. PMID: 31264543 Review.
Cited by
-
Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?Br J Pharmacol. 2017 Nov;174(21):3749-3765. doi: 10.1111/bph.13577. Epub 2016 Sep 20. Br J Pharmacol. 2017. PMID: 27641943 Free PMC article. Review.
-
On the fluorescence enhancement of arch neuronal optogenetic reporters.Nat Commun. 2022 Oct 28;13(1):6432. doi: 10.1038/s41467-022-33993-4. Nat Commun. 2022. PMID: 36307417 Free PMC article.
-
Opportunities and challenges in cardiac tissue engineering from an analysis of two decades of advances.Nat Biomed Eng. 2022 Apr;6(4):327-338. doi: 10.1038/s41551-022-00885-3. Epub 2022 Apr 27. Nat Biomed Eng. 2022. PMID: 35478227 Review.
-
Adeno-Associated Virus Mediated Gene Delivery: Implications for Scalable in vitro and in vivo Cardiac Optogenetic Models.Front Physiol. 2019 Mar 5;10:168. doi: 10.3389/fphys.2019.00168. eCollection 2019. Front Physiol. 2019. PMID: 30890951 Free PMC article.
-
Cardiac subtype characterization using all-optical action potential imaging.Eur Heart J. 2017 Jan 21;38(4):302-304. doi: 10.1093/eurheartj/ehw380. Eur Heart J. 2017. PMID: 28182229 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous